Edgewise Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Edgewise Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
  • Edgewise Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$40.4M, a 37.3% decline year-over-year.
  • Edgewise Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$147M, a 43.5% decline year-over-year.
  • Edgewise Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$114M, a 59.6% decline from 2022.
  • Edgewise Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$71.7M, a 65.8% decline from 2021.
  • Edgewise Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$43.2M, a 151% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$147M -$40.4M -$11M -37.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$136M -$38.1M -$12.8M -50.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$123M -$34.8M -$9.05M -35.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$114M -$33.9M -$11.8M -53.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 -$103M -$29.5M -$11.2M -61.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$91.4M -$25.3M -$8.85M -53.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$82.5M -$25.7M -$10.9M -73.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$71.7M -$22.1M -$9.26M -72.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$62.4M -$18.3M -$5.19M -39.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$57.2M -$16.5M -$6.03M -57.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$51.2M -$14.8M -$7.97M -116% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$43.2M -$12.8M -$6.48M -102% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$36.7M -$13.1M -$9.43M -259% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$27.3M -$10.5M -$6.5M -164% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$20.8M -$6.86M -$3.61M -111% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 -$17.2M -$6.34M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$3.64M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$3.96M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$3.25M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.